Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Supporters often emphasize the possibility for meaningful therapeutic gains, principally in diseases where conventional therapies have proven ineffective. However, crucially important to consider the significant financial burden associated with CPI st